Clinically
Proven Results

With ADVATx®

Acne

ADVATx® delivers a comprehensive solution to active acne by using the 589nm wavelength to reduce redness and kill acne bacteria, while the 1319nm wavelength thermally impacts the sebaceous glands to regulate sebum and oil production. 

Side-by-side comparison of a man's face showing skin improvement. The left side labeled 'Before' shows acne and skin redness. The right side labeled 'After' shows clearer skin.
Side-by-side comparison showing a woman's face before and after skin treatment. The left side shows severe acne with inflamed, red pimples, while the right side shows clear, smooth skin with minimal blemishes. The photo credit goes to Dave Bakos.

Vascular

ADVATx® uses patented SoftPulse technology to target vascular concerns without bruising or purpura. Safely treat a variety of vascular abnormalities with no social downtime and off-the-table results. 

Comparison of a person's mouth before and after ADVATx treatment. Photo credited to Dave Bakos and Dr. Lisa Medwedff.
Comparison of a man's nose and mustache before and after treatment. The 'before' shows a nose with visible damage or skin condition, while the 'after' shows a clearer nose with improved skin. Photo credited to Dave Bakos and Dr. Lisa Medweff.

Scars

With successive treatments, ADVATx® can help reduce the appearance of scars. The 589nm wavelength helps diminish redness and definition, while the 1319nm wavelength helps stimulate collagen synthesis, refining skin texture over time.

Comparison of stretch mark scars before and after treatment, showing improved skin appearance on the right side.
Comparison of a person's skin before and after a an ADVATx treatment, showing a reduction in scars or blemishes.

Melasma

ADVATx® takes a multifaceted approach to melasma with its precise delivery mechanism and unique absorption characteristics. The 589nm wavelength addresses the underlying inflammatory and vascular components, while 1319nm improves overall skin quality, providing effective treatments with a low risk of post-inflammatory hyperpigmentation.

Side-by-side comparison of skin on a person's face before and after treatment, showing improvement in skin tone and texture. The left side shows hyperpigmentation and uneven skin, while the right side shows clearer, more even skin.
Side-by-side comparison of a woman's face showing a skin treatment; the left side labeled 'Before' with visible dark spots, and the right side labeled 'After' showing clearer skin, with makeup applied and no dark spots.

Rosacea

The 589nm wavelength, preferentially absorbed by oxyhemoglobin, allows ADVATx® to combat rosacea by targeting redness, inflammation, and visible blood vessels. This approach results in a lower risk of side effects, such as bruising and swelling.

Side-by-side comparison of a woman's face before and after skin treatment. The before image shows redness and inflammation, while the after image shows clearer, calmer skin.
Side-by-side comparison of a person's face before and after a skincare treatment. The before image shows red, inflamed skin, while the after image shows clearer skin with reduced redness.

Pigment

ADVATx® employs dual wavelengths to effectively target pigment. The 589nm wavelength addresses red and brown pigment with less discomfort than other lasers, while the 1319nm wavelength helps improves overall skin quality, providing effective treatments with a low risk of post-inflammatory hyperpigmentation..

Side-by-side comparison of a woman's face showing 'before' and 'after' skin treatment, highlighting improved skin texture and reduced freckles in the 'after' image. Text indicating 'BEFORE' on the left and 'AFTER' on the right, with a caption crediting Dave Bakos.
Comparison of skin texture before and after a treatment. The 'before' side shows rough, uneven skin with visible pores and blemishes, while the 'after' side depicts smoother, clearer skin. Photo credit: @nepaskinscholar.